HIV

Latest News

FDA Approves Lenacapavir for Prevention of HIV
FDA Approves Lenacapavir for Prevention of HIV

June 18th 2025

The decision makes the therapy the first and only twice-yearly option available in the United States for PrEP.

Home Administration of Long-Acting HIV Therapy is Safe, Effective
Home Administration of Long-Acting HIV Therapy is Safe, Effective

May 3rd 2025

Gilead Presents Data Demonstrating Established, Investigational HIV Drugs
Gilead Presents Data Demonstrating Established, Investigational HIV Drugs

March 15th 2025

Zero Cases of HIV Acquisition Seen for Apretude, Cabenuva Treatment
Zero Cases of HIV Acquisition Seen for Apretude, Cabenuva Treatment

March 14th 2025

Drug Regimen For HIV Shows Non-Inferiority to Antiretroviral Therapies
Drug Regimen For HIV Shows Non-Inferiority to Antiretroviral Therapies

March 14th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.